Call Our Locations With Just One Click

Semaglutide + Cagrilintide Combination Therapy | Medical Weight Loss in Walnut Creek, CA

Semaglutide + Cagrilintide Combination Therapy

Semaglutide-Cagrilintide-Medical-Institute-of-Healthy-Aging-800-x-900-px-.png

A Modern, Dual-Action Approach to Weight Loss and Metabolic Health

For many adults, weight gain is not just about willpower — it’s driven by biology, hormones, and appetite regulation. At MIHA, we offer an advanced solution that addresses these root causes: the Semaglutide + Cagrilintide combination therapy, a physician-guided treatment designed to support sustainable weight loss, appetite control, and better metabolic function.

This protocol combines two powerful agents to help you feel full faster, reduce cravings, and regain control of your health — all under close medical supervision.

Schedule Your Appointment

What Are Semaglutide and Cagrilintide?

Semaglutide is an FDA-approved GLP-1 receptor agonist, originally used to treat type 2 diabetes and now widely recognized for its ability to reduce appetite and promote weight loss (marketed as Wegovy® and Ozempic®).

Cagrilintide is an investigational amylin analog — a hormone that complements semaglutide by enhancing satiety (the feeling of fullness) and further reducing food intake.

When used together, these medications offer dual appetite regulation with the potential for greater weight loss and metabolic improvements than either drug alone.

How the Combination Therapy Works at MIHA

This therapy is part of a personalized weight loss protocol tailored to your body and goals. Medications are administered via subcutaneous injection and monitored closely by our medical team to ensure safety and effectiveness.

Weekly or bi-weekly dosing schedule

Adjusted according to tolerance and response

Physician review of labs, body composition, and metabolic markers

Compounded formulations may be used through trusted pharmacies

You’ll also receive lifestyle support, nutritional guidance, and follow-up consultations to reinforce long-term success.

Older-Woman-Medical-Institute-of-Healthy-Aging-800-x-900-px-.png

By targeting the brain’s hunger and satiety centers, this treatment can lead to:

More significant weight loss compared to monotherapy

Decreased appetite and food cravings

Improved insulin sensitivity and blood sugar regulation

Support for healthier blood pressure and lipid profiles

Reduced inflammation and metabolic strain

More consistent and sustained fat loss (not just water weight)

This therapy may be right for:

Adults struggling with excess weight or obesity

Individuals with insulin resistance or pre-diabetes

Patients who have plateaued with diet and exercise alone

Anyone seeking a medically supervised, science-backed weight loss option

Those looking to support healthy aging by reducing metabolic risk

Note: This therapy is not for individuals with a history of medullary thyroid cancer, pancreatitis, or specific endocrine disorders. A full consultation and screening are required.

Get in Touch Today

More Than Weight Loss — A Health Reset

At MIHA, weight loss is not about appearance — it’s about function, vitality, and long-term disease prevention. This dual therapy is one of the most effective tools we offer to reset your biology and help you feel in control of your health again.